Astrazeneca Pharma India Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹315.45Cr |
Net Profits | ₹15.80Cr |
Net Profit Margins | 5.01% |
Highlights
Revenue:
Astrazeneca Pharma India Ltd’s revenue jumped 22.74% since last year same period to ₹315.45Cr in the Q3 2023-2024. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -6.08% fall in its revenue since last 3-months.
Net Profits:
Astrazeneca Pharma India Ltd’s net profit fell -46.08% since last year same period to ₹15.80Cr in the Q3 2023-2024. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -69.83% fall in its net profits since last 3-months.
Net Profit Margins:
Astrazeneca Pharma India Ltd’s net profit margin fell -56.07% since last year same period to 5.01% in the Q3 2023-2024. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -67.88% fall in its net profit margins since last 3-months.
